SEC-sourced researchBeta
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Company comparison ↗
Data passport
- CIK
- 0001946563
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 14, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 607,574.0000 | Mar 30, 2026 |
| December 2025 | 1,005,471.0000 | Mar 30, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,005,471.0000 | -7,365,158.0000 | -6,849,022.0000 | 5,366,211.0000 | 1,986,795.0000 | Mar 30, 2026 |
| December 2024 | 607,574.0000 | -7,947,107.0000 | -5,648,088.0000 | 5,759,345.0000 | 1,804,339.0000 | Mar 30, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.01M | December 2025 | Mar 30, 2026 | 10-K |
| Previous period revenueRevenues | $607.57K | December 2024 | Mar 30, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$7.37M | December 2025 | Mar 30, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$6.85M | December 2025 | Mar 30, 2026 | 10-K |
| Total assetsAssets | $5.37M | December 2025 | Mar 30, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.99M | December 2025 | Mar 30, 2026 | 10-K |